Scarica l'app Stockscreener
4.49
0.45%
0.02
Precedente Chiudi:
$4.47
Aprire:
$4.52
Volume 24 ore:
37,823
Relative Volume:
0.29
Capitalizzazione di mercato:
$82.33M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-4.7766
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+6.15%
1M Prestazione:
+24.03%
6M Prestazione:
+65.07%
1 anno Prestazione:
+220.71%
Intervallo 1D:
$4.2575
$4.52
Intervallo di 1 settimana:
$4.10
$4.7899
Portata 52W:
$1.3188
$6.22
Exagen Inc Stock (XGN) Company Profile
Nome
Exagen Inc
Settore
Industria
Telefono
(760) 560-1501
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Confronta XGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
4.49 | 82.33M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-04-15 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cowen | Outperform |
| 2019-10-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Exagen Inc Borsa (XGN) Ultime notizie
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen Inc. (NASDAQ:XGN) Shares Sold by Prudential Financial Inc. - Defense World
Corient Private Wealth LLC Invests $45,000 in Exagen Inc. (NASDAQ:XGN) - Defense World
There's No Escaping Exagen Inc.'s (NASDAQ:XGN) Muted Revenues Despite A 45% Share Price Rise - simplywall.st
Virtu Financial LLC Purchases New Position in Exagen Inc. (NASDAQ:XGN) - Defense World
Short Interest in Exagen Inc. (NASDAQ:XGN) Drops By 23.5% - The AM Reporter
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates - MSN
Exagen Inc. sees $1.16 million stock sale by NMSIC Co-Investment Fund By Investing.com - Investing.com Philippines
Major Shareholder Sells Off Huge Chunk of Exagen Stock! - TipRanks
FY2025 EPS Estimates for Exagen Lowered by Cantor Fitzgerald - Defense World
Equities Analysts Offer Predictions for Exagen Q1 Earnings - Defense World
Exagen Inc. (NASDAQ:XGN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo
William Blair Reaffirms “Outperform” Rating for Exagen (NASDAQ:XGN) - Defense World
FY2026 Earnings Forecast for Exagen Issued By William Blair - Defense World
FY2024 EPS Estimates for Exagen Raised by Cantor Fitzgerald - Defense World
Exagen Inc. Reports Record Revenue and Positive Outlook - TipRanks
Exagen Inc. (NASDAQ:XGN) Q4 2024 Earnings Call Transcript - Insider Monkey
Exagen Full Year 2024 Earnings: EPS Beats Expectations - Yahoo
Exagen’s Positive Outlook: Buy Rating Backed by Strong Performance and Growth Potential - TipRanks
Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - Yahoo
Exagen Inc. Reports Record 2024 Financial Results - TipRanks
BTIG maintains Buy rating, $5 target on Exagen stock - Investing.com
BTIG maintains Buy rating, $5 target on Exagen stock By Investing.com - Investing.com Australia
Earnings call transcript: Exagen Inc Q4 2024 sees revenue growth and stock rise - Investing.com
Exagen posts smaller-than-expected fourth-quarter net loss -March 11, 2025 at 09:39 am EDT - Marketscreener.com
Exagen Inc reports results for the quarter ended December 31Earnings Summary - TradingView
EXAGEN INC. SEC 10-K Report - TradingView
EXAGEN DIAGNOSTICS Earnings Results: $XGN Reports Quarterly Earnings - Nasdaq
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights - The Manila Times
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results - TradingView
EXAGEN DIAGNOSTICS Earnings Preview: Recent $XGN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Exagen (XGN) Expected to Announce Earnings on Tuesday - Defense World
Is Exagen (NASDAQ:XGN) Using Debt In A Risky Way? - Simply Wall St
Investors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five years - Yahoo
Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025 - GlobeNewswire
When Will Exagen Report Q4 Earnings? Key Date for Autoimmune Testing Investors - StockTitan
Stocks Surge Across Health Services and Industry Sectors: Nuvve, Exagen, and Flexsteel Lead the Way - HPBL
What Do Wall Street Analysts Think About Exagen Inc (NASDAQ: XGN) Stock? - Stocks Register
Exagen Inc. (NASDAQ:XGN) Short Interest Up 260.8% in January - MarketBeat
Exagen Inc Azioni (XGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):